Researchers
Đanić, Maja
Results 121-140 of 267
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2018 | In vitro study of gliclazide-probiotic bacteria interactions![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2018 | Kandida i njen permanentni značaj u infekcijama urinarnog trakta kod ljudi | Smieško G; MIKOV, MOMIR M. | Article | 53M53 |
| 2018 | 12-Monoketocholate: a new perspective in metabolic syndrome treatment![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2018 | Transport and biotransformation of gliclazide in probiotic bacteria![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2018 | 12-Oxo-chenodeoxycholic acid potentiates doxorubicin-induced oxidative stress through Nrf2 axis in breast adenocarcinoma cells![]() | Stanimirov, Bojan | Conference Paper | Mp. category will be shown later |
| 2018 | Lekovi u prometu 2018 : priručnik o lekovima i njihovoj primeni![]() | Sabo, Ana
Milijašević, Boris
| Other | Mp. category will be shown later |
| 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | STANIMIROV, BOJAN G. | Conference Paper | Mp. category will be shown later |
| 2018 | 12-MKC: a novel approach for metabolic syndrome treatment | LAZAREVIĆ, SLAVICA | Conference Paper | Mp. category will be shown later |
| 2018 | Qualitative analysis of simvastatin metabolites arising from probiotic bacteria - in vitro study![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2018 | Preliminary study on gliclazide–probiotic bacteria interactions in in vitro conditions | ĐANIĆ, MAJA P. | Conference Paper | Mp. category will be shown later |
| 2018 | Lečenje kandidurije | Smieško G; MIKOV, MOMIR M. | Article | 53M53 |
| 2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics![]() | Mikov, Momir | Article | 23M23 |
| 2018 | Interakcije između gliklazida i probiotskih bakterija u in vitro uslovima![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2017 | Nova perspektiva tretmana dijabetes mellitusa: mesto žučnih kiselina, probiotika i gliklazida kao mogući tretman dijabetesa tip 1 | MIKOV, MOMIR M. | Conference Paper | Mp. category will be shown later |
| 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | STANIMIROV, BOJAN G. | Conference Paper | Mp. category will be shown later |
| 2017 | Preliminary study on probiotic bacteria role in simvastatin activation![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2017 | M In silico prediction of bile acids-drugs interactions at transporter level of Lactobacillus Acidophilus NCFM![]() | Stojančević, Tijana | Conference Paper | Mp. category will be shown later |
| 2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Mikov, Momir | Article | 22M22 |
| 2017 | Lekovi u prometu 2017 : priručnik o lekovima i njihovoj primeni![]() | Sabo, Ana
Milijašević, Boris
| Other | Mp. category will be shown later |
| 2017 | Bioactivation of simvastatin by probiotic bacteria: in vitro study | Đanić, Maja | Conference Paper | Mp. category will be shown later |
